Aging (Aging-US) and FOXO Present: The Longevity & Aging Series

06-22-2022

Listen to an audio version of this press release

BUFFALO, NY- June 22, 2022 – Aging (Aging-US) and FOXO Technologies have teamed up to present a special collaboration on aging research with a new limited series: the Longevity & Aging Series. This series of video interviews invites Aging researchers to speak with researcher and host Dr. Brian Chen. Dr. Chen is an adjunct faculty member at the Herbert Wertheim School of Public Health and Human Longevity Science at the University of California San Diego.

The Longevity & Aging Series offers a platform for Aging authors to discuss their aging research in a long-form video format. Dr. Chen will invite distinguished authors to present their research studies and results published in Aging (Aging-US). Upcoming author interviews include Drs. Alex Zhavoronkov, Frank Pun, Steve Horvath, Andrew DiNardo, Cristian Coarfa, Carly Bobak, and Amit Sharma.

The goal of this collaboration between Aging (Aging-US) and FOXO Technologies is to foster the rapid dissemination of research, encourage thought leadership and jumpstart new breakthrough studies in the field of aging.

The series will be available to watch on our YouTube and LabTube channels, and will also be available for listeners on Spotify, SoundCloud or wherever high-quality podcasts are downloaded. In addition, Longevity & Aging Series discussions will be posted on Aging-US.com and Aging-US.net, and promoted across our family of social media channels.

“This is an exciting partnership between FOXO and Aging,” Dr. Chen said. “Remarkable breakthroughs are emerging every day in aging and healthy longevity. I hope this series helps to promote all the exciting work that is being done to a broader audience.” 

AVAILABLE NOW:

Episode One - Drs. Alex Zhavoronkov and Frank Pun

About Aging-US:

Aging publishes research papers in all fields of aging research including but not limited, aging from yeast to mammals, cellular senescence, age-related diseases such as cancer and Alzheimer’s diseases and their prevention and treatment, anti-aging strategies and drug development and especially the role of signal transduction pathways such as mTOR in aging and potential approaches to modulate these signaling pathways to extend lifespan. The journal aims to promote treatment of age-related diseases by slowing down aging, validation of anti-aging drugs by treating age-related diseases, prevention of cancer by inhibiting aging. Cancer and COVID-19 are age-related diseases.

Aging is indexed by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed CentralWeb of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Please visit our website at www.Aging-US.com and connect with us:

For media inquiries, please contact media@impactjournals.com.